Fluoxetine epigenetically alters the CaMKII promoter in nucleus accumbens to regulate δfosb binding and antidepressant effects

A. J. Robison, Vincent Vialou, Hao Sheng Sun, Benoit Labonte, Sam A Golden, Caroline Dias, Gustavo Turecki, Carol Tamminga, Scott Russo, Michelle Mazei-Robison, Eric J. Nestler

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Fingerprint Dive into the research topics of 'Fluoxetine epigenetically alters the CaMKII promoter in nucleus accumbens to regulate δfosb binding and antidepressant effects'. Together they form a unique fingerprint.

Medicine & Life Sciences